A Fluorogenic Click' Reaction of Azidoanthracene Derivatives
A Fluorogenic Click' Reaction of Azidoanthracene Derivatives
A Fluorogenic Click' Reaction of Azidoanthracene Derivatives
com
Abstract Fluorogenic reactions have broad applications in biolabeling, combinatorial synthesis of uorescent dyes, and materials development. It was recently reported that the highly selective and efcient Cu(I)-catalyzed azideealkyne cycloaddition (CuAAC) reaction can be employed in designing new types of uorogenic reactions. In this study, we report a uorogenic reaction using anthracene azides as starting materials. The uorescence of the anthryl core can be greatly inhibited upon introducing electron-donating azido groups in the proximity. Such weakly uorescent anthracene azides demonstrate high reactivity with a variety of alkynes under the CuAAC conditions producing a strongly uorescent triazole product with high quantum yields. This reaction can be used in the synthesis and screening of uorescent dyes combinatorially. Compared with most existing methods, the uorogenic CuAAC reaction is a much milder and simpler technique to prepare large libraries of uorescent dyes without further purication. In order to demonstrate the efciency of using anthracene azides for biolabeling applications, both small molecules and biomolecules including the multialkyne-derivatized cowpea mosaic virus and tobacco mosaic virus had been studied. 2008 Elsevier Ltd. All rights reserved.
1. Introduction Incorporation of exogenous natural or unnatural tags into proteins and glycans by cellular biosynthetic pathways is an emerging strategy for investigating their cellular activities.1e3 Since these processes involve multistep enzymatic transformations that prohibit the incorporation of large signaling moieties, chemoselective reactions are often employed for postlabeling.1,3e6 In this case, a bioorthogonal uorogenic reaction is invaluable, in which the unreacted reagents show no uorescent background and the purication can be avoided.5,7,8 Being a highly energetic functional group, the organic azide is stable and unreactive with most biomolecules under physiological conditions. Recently, it has been employed as a tag for sequential bioorthogonal labeling via the Bertozzie Staudinger ligation or the Cu(I)-catalyzed azideealkyne cycloaddition (CuAAC) reaction.4,6,9e11 Consequently, the uorogenic versions of BertozzieStaudinger ligation and
* Corresponding author. Tel.: 1 803 777 8436; fax: 1 803 777 9521. E-mail address: [email protected] (Q. Wang). 0040-4020/$ - see front matter 2008 Elsevier Ltd. All rights reserved. doi:10.1016/j.tet.2008.01.080
CuAAC reactions have been reported.7,12e15 A representative uorogenic dye developed in our laboratory, 3-azido-7-hydroxycoumarin, has been successfully used for the labeling and visualization of synthesized proteins in different cells and other polymeric systems via the CuAAC reaction.8,16 Compared to the coumarin uorophore, some anthracene derivatives have much higher quantum yields, e.g., 9,10-diphenylanthracene is used as a uorescent standard in quantum yield determination. In addition, photoinduced electron transfer (PET) process of anthracenes has been widely applied in ion sensing,17 singlet oxygen detection,18 screening catalysts,19 molecular logic gate construction,20 and cell labeling by recognition of carbohydrates.21 We therefore exploit the possibility to design a new type of uorogenic reaction based on the PET process of anthracenes. Due to the high electron density of the a-nitrogen of azido group,13,14 it was envisioned that the introduction of the azido group close to the anthryl core via a non-conjugated linker would lead to a favorable electron transfer from the azido to the excited anthryl core and induce the quenching of uorescence. After the CuAAC reaction, the lone pair electrons on nitrogen will become part of the aromatic system and become a much weaker electron donor.
2907
Therefore, the uorescence of the anthryl core will be remediated resulting in a uorogenic phenomenon. In this paper, we report the synthesis of ve novel azido derivatized anthracenes and applied the CuAAC reaction to activate their uorescence. This method was applied to label multiple alkyne organic molecules and large alkyne functionalized biological macromolecules. 2. Results and discussion Compound A was rst synthesized and then reacted with phenylacetylene (1) as shown in Scheme 1.17 The cycloaddition reaction was performed using catalytic amounts of copper sulfate and sodium ascorbate (NaAsc) in a solution of DMF and water (v/v1:1).13,22 At the same concentration in pure DMSO, while the triazolyl product A1 shows almost the same absorption intensity as A, its uorescent emission intensity is 75-fold stronger than that of A (Fig. 1). The quantum yield of A1 is 0.96, much higher than that of A (w0.02). Moreover, it should be noticed that there is no shift in emission and excitation wavelength accompanying the change of uorescence intensity. All these results indicate a PET process between azido group and anthryl core that can be adopted for designing a new type of uorogenic CuAAC reaction. In order to examine the scope of the uorogenic CuAAC reaction of anthracene derivatives, four more anthracene azides (BeE) were synthesized via easy transformations (Scheme 2). Azido groups were attached to the anthracene core at 1-, 2- or 9-position. In all cases, the uorescence was quenched efciently. All azides are quite stable and no decomposition has been found after storing on the shelf or reuxing in toluene for a long period of time. Each azide
exhibited high reactivity with a variety of alkynes regardless of the structures under standard CuAAC condition (see Table 1).22,23 A comparison between the maximum emission intensity of the cycloaddition products A1eE1 and that of the corresponding azides is shown in Figure 2. The uorescent emission of all triazole products is enhanced dramatically compared to the starting azides except C, which shows a noticeable uorescence and a bathochromic shift of uorescence due to the introduction of 9-cyano group (Fig. S1). Since the CuAAC reaction can tolerate a great diversity of the structural features of azides and alkynes, it is possible to screen the uorescent properties of the cycloaddition products in relation to the starting alkynes combinatorially. In our study, 5 different anthracene azides AeE and 34 terminal alkynes 2e 35 (Table 2) were loaded in microtiter plates. Each well thus represented a unique combination of anthracene and alkyne. The total volume of each reaction mixture was 200 mL (DMSOeH2O1:1) containing 1 mM azide and alkyne catalyzed with 2 mM CuSO4 and 5 mM NaAsc. Most reactions were completed in 24 h at room temperature as monitored by TLC or mass spectrometry. The formation of the uorescent triazole products is easily visualized upon irradiation at 365 nm with a hand-held UV lamp. Without purication the emission of reaction mixtures was directly evaluated using a Varian Eclipse uoriphotometer. As shown in Figure 3 and Table S1 in Supplementary data, most triazole products of azides A and B had distinct enhancement in uorescent intensity regardless of the structures of alkynes. Although some factors like reaction yield and coordination with Cu2 or Cu ion would inuence the emission intensity of products,17 we still can get useful information on the uorescent properties of the nal products.
NaN3 DMF Cl A N3
Figure 1. Comparison of uorescent emission (left, excited at 370 nm) and absorption spectra (right) of A and A1 in DMSO (10 mM for emission spectra and 50 mM for absorption spectra).
2908
OH
CHO 1b
56%
CHO 2b OAc
N3 B N3
CN
30%
1c COOH Et2O LiAlH4 85% 1d 2d HO 1. MsCl, Et3N, CH2Cl2 2. NaN3, DMF 73%
CN C
N3
NH2
N3
1e
Since CuAAC reaction can tolerate a variety of solvents (including water), pH ranges, and be compatible to most of the functionalities, azide and alkyne groups have been broadly used as biocompatible/chemocompatible tags for biomacromolecules and polymers. The uorogenic CuAAC reaction reported here can therefore be used in the post-labeling of polyvalent alkyne displayed systems, in particular, in a biological environment. We chose trispropynyloxybenzene (37), alkyne-derivatized cowpea mosaic virus (CPMV), and tobacco mosaic virus (TMV), which have 3, 60, and 2130 terminal alkyne units, respectively, as multivalent model systems to demonstrate the feasibility of this selective post-labeling strategy. Catalyzed with in situ generated Cu(I), 37 can be uorescently derivatized by A in high efciency (Scheme 3). As previously reported, CPMV has been employed as a nano building block for many organic reactions.24e28 N-Hydroxysuccinimidal ester of 34 was synthesized and used to attach terminal alkynes to the reactive lysines of CPMV.29 The newly synthesized CPMVeAlkyne was sequentially subjected to the CuAAC reaction with B catalyzed through the addition of CuBr and a bathophenanthroline ligand (Scheme 3).30 Gel electrophoresis conrmed the covalent attachment of uorescent anthracene units on CPMV after cycloaddition reaction (Fig. 4A). The integrity of the CPMV products was conrmed by TEM and size-exclusion chromatography (Fig. 4B and C). Due to the strong uorescence of the cycloaddition product (the quantum yield of the model compound B34 is 0.51 as compared to azide B F0.02), as low as 0.5 nM of the cycloaddition product could be detected without the interference of starting materials. Similarly, the versatility of this uorogenic reaction is demonstrated via the CuAAC reaction on the surface of TMV,
a rod-like particle consisting of 2130 identical protein subunits arranged helically around a single RNA strand.31 TMV is initially subjected to an electrophilic substitution reaction at the ortho-position of the phenol ring of tyrosine-139 residues with diazonium salts to insert the alkyne functionality.32 MALDI-TOF MS analysis indicated that >95% of the capsid monomers were converted into alkyne derivatives (Fig. 5A). The sequential CuAAC reaction is achieved with greatest efciency using a combination of CuSO4 with NaAsc (Scheme 3).33 The efciency of the reaction is easily monitored using MALDI-TOF MS (Fig. 5A) with shift in mass from 17,664 m/z (TMVeAlkyne) to 17,918 m/z (TMVeAnthracene) and UVevis absorption in the 380e420 nm range (Fig. 5C). Due to the often destructive nature of organic reactions on viral particles, the stability of TMV was monitored by TEM analysis (Fig. 5B) in conjunction with size-exclusion chromatography (Fig. S9) and was found to remain intact and stable throughout the reaction.33 3. Conclusions In summary, we report here a new bioorthogonal uorogenic reaction based on the PET principle, which affords an efcient way to link two entities together while the conjugating efciencies could be reported by the uorescent emission assays. It should have broad application in the emerging eld of cell biology and functional proteomics due to the high reaction efciency of CuAAC reaction at mild reaction conditions and the distinct uorescence properties of products. The high reactivity and selectivity between azides and terminal alkynes allow further applications in ligating other biomolecules, polymers, nanoparticles and surfaces, which are under exploration. In addition, since it is generally difcult to construct the
F. Xie et al. / Tetrahedron 64 (2008) 2906e2914 Table 1 CuAAC reactions of anthracene azides AeE with some typical alkynes Entry Azide Alkyne Product
N N N A1 N N N Cl A7 N N N
C1 N N N NC
2909
Alkyne
Product
N N N
Yielda (%)
C6H13
95
HO
93c
B26
Cl
66
10
81
71
11
N N N D1
97
A17 N N N C6H13
86
12
N N
93
D11
A26 N N N HO
HO
92
13
N N N
C6H13 D26
97
A36 N N N
HO
69
14
HO
N N N
HO
60
D36 N N N E1
B1 N N N
HO
63c
B3
15
66
B
F3C
HO
N N N
CF3
79
16
HO
N N N E27
OH
67
B14
a b c
Isolated yields. Quantum yields of azide A and the product A1 are 0.02 and 0.97. Quantum yields: B 0.02, B3 0.95, B14 0.95, and B26 0.97.
highly conjugated uorophore, only a few reactions have been applied in the combinatorial synthesis of uorescent compounds including condensation reactions using aldehydes and transition metal catalyzed coupling reactions.34e39 The CuAAC reaction distinguishes from others by its mild reaction conditions and high transformation efciency regardless of the structures of azides and alkynes, which make it an ideal reaction to synthesize uorescent dyes in a combinatorial manner.
4. Experimental section 4.1. General methods Unless otherwise noted, all chemicals and solvents were obtained from commercial suppliers and used without purication. 1H NMR spectra were recorded on Varian 300 NMR spectrometer and 13C NMR spectra were recorded either on Varian 300 NMR or on Varian 400 NMR spectrometer. The
2910
1000 900 Emission Intensity (a.u.) 800 700 600 500 400 300 200 100 0 A A1 B B1 C C1
ZipTip-C18 tips to remove the salts before the MS analysis. The quantum yields of anthracene derivatives were determined using a literature method.40 4.2. Synthesis of azides The preparation of A,17,41 1b,42 and 1d43 has previously been described.
D D1 E E1
Figure 2. The comparison between the maximum emission intensity of anthracene azides (AeE) and their respective product with alkyne 1. All samples were measured in DMSO solution ([c]10 mM). The original spectra are given in Supplementary data.
UVevis absorption spectra were measured on Agilent 8453 spectrometer. Emission spectra were measured on Varian Cary Eclipse uorescence spectrophotometer. Ultracentrifugation was performed at the indicated speeds using a Beckman Optima L-90K Ultracentrifuge equipped with either SW41 or 50.2 Ti rotors. TEM analyses of viruses were carried out by depositing 20 mL aliquots of each sample at a concentration of 0.1e0.3 mg/mL onto 100-mesh carbon-coated copper grids for 2 min. The grids were then stained with 20 mL of 2% uranyl acetate and viewed with a Hitachi H-8000 TEM electron microscope. MALDI-TOF MS analyses of viral subunit were carried out using a Bruker Ultra-Flex I TOF/TOF mass spectrometer with MS grade sinapinic acid in 70% acetonitrile and 0.1% TFA as the matrix. In general, the viruses were denatured after being treated with guanidinium-HCl (6.0 M, 4 mL) for 5 min at room temperature. The denatured protein was spotted onto a MALDI plate using Millipore
Table 2 The alkyne building blocks used in this study
4.2.1. 10-Azidomethylanthracene-9-carbaldehyde (2b) To the stirred suspension of 1b (5.22 g, 22 mmol) in 200 mL dry CH2Cl2 and 200 mL dry acetonitrile under nitrogen at 0 C were added dry triethylamine (3.35 g, 33 mmol) and methanesulfonyl chloride (3.15 g, 27.5 mmol). The mixture was stirred at room temperature for 4 h under nitrogen before an aq HCl (1 N, 70 mL) was added to the resulting solution. The organic layer was washed by water (50 mL2) and brine, and dried over anhydrous Na2SO4. The solvent was removed under reduced pressure and the residue was dried under vacuum. The resulted solid was dissolved in DMF (250 mL), and NaN3 (2.1 g, 33 mmol) was added. The mixture was stirred at room temperature overnight. Water (200 mL) and ethyl acetate (EtOAc, 200 mL) were added. The aqueous layer was extracted by EtOAc (50 mL2) and the combined organic layers were washed with brine and dried over anhydrous Na2SO4. The solvent was removed under reduced pressure and the residue was puried by ash chromatography on silica gel (EtOAcehexane1:9 to 1:4) to give 2b as a yellow solid (3.1 g, 56%). 1H NMR (300 MHz, CDCl3): d11.5 (s, 1H), 8.92e8.88 (m, 2H), 8.41e8.38 (m, 2H), 7.74e7.65 (m, 4H), 5.37 (s, 2H); 13C NMR (75 MHz, CDCl3) d194.0, 133.7, 131.2, 130.4, 128.6, 127.7, 127.2, 124.6, 124.5, 46.6.
F 4 F 5 6
F 7
Cl 8
Br
H2N 9
HO 10
O 11
O 12
F3C 13 HO N CF3 21 OH
F3C 14
C5H11
N 15 N 16 17
H2N N 22 N
18 OH
19
20
23 OH
24
HO 28 O O OH 34 HN 35 29
HO 30
25
26
27
O OH
HO
Cl 31 32 HO 33
HN
36
2911
Figure 3. Schematic demonstration of the well plate reactions between azidoanthracenes (AeE) and alkynes (2e35). Each cells color represents the emission property of every compound based on the values of Hue, Sat and Lum in an HSL color model. Hue value represents the maximum emission wavelength of each compound and Lum value represents the maximum emission intensity (more details could be found in Supplementary data).
4.2.2. (10-Azidomethylanthracen-9-yl)methanol (B) NaBH4 was added in small portions to the suspension of 2b (360 mg, 1.38 mmol) in 50 mL ethanol at 0 C. The reaction mixture was stirred at room temperature for 8 h. Concentrated HCl solution was added dropwise carefully to destroy the unreacted NaBH4 and then water was added until pH was neutral. Dichloromethane (150 mL) was added and the organic layer was separated, washed with brine, and dried over anhydrous Na2SO4. The solvents were removed under reduced pressure and the residue was puried by ash chromatography on silica gel (EtOAcehexane1:4) to give B as a yellow solid (300 mg, 83%). 1H NMR (300 MHz, DMSO): d8.57e8.47 (m, 4H), 7.67e7.60 (m, 4H), 5.52 (s, 2H), 5.49e5.41 (m,
3H); 13C NMR (75 MHz, DMSO) d135.6, 130.8, 130.2, 127.5, 126.9, 126.3, 125.2, 56.2, 46.3. HRMS calculated for C16H13N3O (M): 263.1059, found: 263.1055. 4.2.3. Acetic acid (10-cyanoanthracen-9-yl)methyl ester (1c) To a suspension of 1b (0.81 g, 3.43 mmol) in 19 mL of 95% EtOH (19 mL) was added hydroxylamine hydrochloride (280 mg, 4.02 mmol, neutralized with Na2CO3) in 4 mL of water. The mixture was heated on a steam bath for 30 min, cooled, and diluted with water. The solid was collected, dried under low pressure, and then acetic anhydride (16 mL) was added. The resulting solution was reuxed for 8 h and then added ice water. Yellow precipitate was collected by ltration,
Scheme 3. Reaction conditions: (i) A, CuSO4, NaAsc, DMFeH2O1:1, 24 h; (ii) B, CuBr, bathophenanthroline, pH 8.5 buffereDMF4:1, 24 h; (iii) B, CuSO4, NaAsc, pH 8.5 buffereDMF4:1, 24 h.
2912
C
Intensity (a.u.)
Intact Particles
with vigorous stirring. The mixture was then stirred at room temperature under nitrogen for 30 min and reuxed for additional 8 h. The reaction was quenched with water (10 mL) and concentrated aq HCl (20 mL). The aqueous solution was separated and extracted by EtOAc (50 mL2). The combined organic solution was washed with aq HCl (1 N, 20 mL), saturated aq NaHCO3 (20 mL), and H2O (20 mL), and dried on anhydrous Na2SO4 to yield crude product 2d (3.2 g, 85%). 1H NMR (300 MHz, DMSO): d8.69 (s, 1H), 8.58 (s, 1H), 8.13e 8.05 (m, 2H), 8.00 (d, J8.4 Hz, 1H), 7.57e7.45 (m, 4H), 5.46 (t, J5.1 Hz, 1H), 5.12 (d, J5.1 Hz, 2H); 13C NMR (75 MHz, DMSO): d138.5, 132.1, 131.7, 131.5, 129.7, 129.1, 128.5, 128.2, 127.2, 126.3, 126.2, 125.8, 124.1, 122.9, 62.0. HRMS calculated for C15H12O (M): 208.0888, found: 208.0889. 4.2.6. 1-Azidomethylanthracene (D) The similar procedure of preparation of 2b was followed to prepare D as a yellow solid (yield 73%). 1H NMR (300 MHz, CDCl3): d8.57 (s, 1H), 8.47 (s, 1H), 8.08e7.99 (m, 3H), 7.54e7.40 (m, 4H), 4.88 (s, 2H); 13C NMR (75 MHz, CDCl3): d132.2, 131.9, 131.2, 130.1, 129.7, 128.8, 128.2, 127.6, 127.1, 126.1, 126.0, 124.7, 122.6, 53.7. HRMS calculated for C16H15N3 (M): 233.0953, found: 233.0945. 4.2.7. 2-Azidoanthracene (E) A solution of sodium nitrite (220 mg, 3.13 mmol) in water (8 mL) was added dropwise to a solution of 1e (450 mg, 2.45 mmol) in water (15 mL) and concentrated sulfuric acid (3 mL) at 0 C over 5 min. The reaction mixture was stirred at 0 C for 30 min before a solution of sodium azide (0.3 g, 4.4 mmol) in water (5 mL) was added dropwise over 10 min. The solution was slowly warmed to room temperature and kept stirring for 5 h. The precipitate was isolated by ltration, washed with water, and puried by column chromatography on a silica column to yield a yellow solid E (260 mg, 51%). 1 H NMR (300 MHz, CDCl3): d8.40 (s, 1H), 8.32 (s, 1H), 8.02e7.96 (m, 3H), 7.59 (m, 1H), 7.63e7.42 (m, 2H), 7.17e 7.13 (dd, J9.0, 2.4 Hz, 1H); 13C NMR (100 MHz, DMSO): d136.4, 131.8, 131.3, 130.8, 128.9, 128.2, 127.8, 126.4, 126.1, 125.5, 124.9, 119.4, 115.0. HRMS calculated for C14H9N3 (M): 219.0796, found: 219.0799. 4.3. Typical experimental procedure for preparative scale CuAAC reactions Azide A (69 mg, 0.30 mmol) and phenylacetylene (31 mg, 0.30 mmol) were suspended in a 3:1 mixture (v/v) of DMF and water (24 mL). Copper sulfate (7 mg, 0.045 mmol), sodium ascorbate (14 mg, 0.09 mmol), and tris[(N-benzyltriazolyl)methyl]amine ligand9 (8 mg, 0.015 mmol) were added. The mixture was then stirred at room temperature for 16e24 h (monitored by TLC). After the reaction was complete, EtOAc (20 mL2) was added to extract the product. The combined organic layers were washed with brine and dried over anhydrous Na2SO4. The solvent was removed under reduced pressure and the residue was puried by ash chromatography on
Broken Particles
10
20
30
washed with water, and nally puried by ash chromatography on silica gel (EtOAcehexane1:9 to 1:4) to give 1c as a light yellow solid (0.70 g, 74%). 1H NMR (300 MHz, CDCl3): d8.52e8.43 (dm, J7.2 Hz, 4H), 7.78e7.67 (m, 4H), 6.16 (s, 2H), 2.09 (s, 3H); 13C NMR (75 MHz, DMSO) d171.1, 133.4, 133.1, 130.4, 128.8, 127.7, 126.4, 125.1, 117.3, 108.3, 58.4, 21.1. 4.2.4. 10-Azidomethylanthracene-9-carbonitrile (C) To the stirred suspension of 1c (220 mg, 0.8 mmol) in methanol (40 mL) and water (10 mL) was added potassium carbonate (237 mg, 60 mmol). The mixture was stirred at room temperature overnight before EtOAc (100 mL) was added into the reaction mixture. The organic layer was washed by aq HCl (1.0 N, 50 mL) and brine, and dried over anhydrous Na2SO4. The solvent was removed under reduced pressure and the residue was dried under vacuum. A similar procedure of preparation of B was followed to yield C as a yellow solid (60 mg, overall yield 30% from 1c). 1H NMR (300 MHz, CDCl3): d8.53 (dm, J7.8 Hz, 2H), 8.39 (dm, J7.8 Hz, 2H), 7.80e7.69 (m, 4H), 5.37 (s, 2H); 13C NMR (75 MHz, CDCl3): d133.2, 133.0, 130.1, 128.9, 127.9, 126.7, 124.6, 46.4. HRMS calculated for C16H10N4 (M): 258.0905, found: 258.0908. 4.2.5. Anthracen-1-ylmethanol (2d) To the dispersion of 1d (4.0 g, 18 mmol) in dry ether (250 mL), LiAlH4 (0.9 g, 26 mmol) was added in portions
2913
A
17918 (17925) TMV-Anthracene
C
Absorbance (A.U.)
17534 TMV
16000
17000
18000
19000
250
300
350
400
450
500
550
600
Wavelength (nm)
Figure 5. (A) MALDI-TOF MS data of TMV, TMVeAlkyne, and TMVeAnthracene indicating >95% reactivity per subunit. (Numbers in parenthesis refer to the expected masses.) (B) TEM image of TMV post-CuAAC functionalization with anthracene. The scale bar is 200 nm. (C) UVevis spectra of TMV and TMVe Anthracene.
silica gel (EtOAcehexane1:9 to 1:4) to yield compound A1 as a yellow solid (0.095 g, 95%). 4.4. Typical experimental procedure of combinatorial CuAAC reactions on a 96-microwell plate The reaction mixture in each well contained a solution of anthracene azides (1.0 mM), alkynes (1.0 mM), copper sulfate (2.0 mM), sodium ascorbate (10.0 mM), and tris[(N-benzyltriazolyl)methyl]amine ligand (0.1 mM) in 200 mL DMSOe water (v/v1:1). For each of the ve anthracene azides one control test was performed, which contained all the above components of the reaction except the alkyne. The reactions including the control test were allowed to incubate at room temperature for 24 h. Then the mixture in each well was diluted 100 times before the uorescence intensity was measured accordingly at proper excitation wavelength. The excitation wavelength was taken as the maximum of the band in the UV spectrum. 4.5. Multivalent CuAAC reactions of azidoanthracenesd reaction of alkyne 37 with azide A By following the protocol of preparative scale CuAAC reactions, 38 was obtained as a yellow solid (85%). 1H NMR (300 MHz, DMSO): d8.68 (s, 2H), 8.61 (s, 1H), 8.57e8.50
(m, 6H), 8.10 (d, J8.7 Hz, 4H), 8.05 (d, J8.4 Hz, 2H), 7.99 (s, 2H), 7.84 (s, 1H), 7.60e7.43 (m, 12H), 6.75 (t, J 7.8 Hz, 1H), 6.59e6.56 (m, 6H), 6.47 (s, 2H), 4.78 (s, 4H), 4.70 (s, 2H); 13C NMR (100 MHz, DMSO): d152.5, 144.1, 143.3, 137.4, 131.7, 131.6, 131.0, 130.9, 129.7, 129.6, 127.8, 127.7, 126.5, 126.4, 126.0, 125.9, 124.8, 124.7, 124.6, 124.2, 108.2, 65.9, 62.4, 46.1, 45.9. HRMS calculated for C60H45N9O3 (M): 940.3723, found: 940.3707. 4.6. Labeling of alkyne-derivatized CPMV with azide B Multialkyne-derivatized CPMV was synthesized according to the literature protocol.9 A mixture of CPMVeAlkyne (4 mg/mL), bathophenanthroline ligand (4 mM), CuBr (1 mM), and anthracene azide B (100 mM) in HEPES buffer (pH8.5) solution (containing 20% DMF) was incubated at 4 C for 24 h with nitrogen. CPMVeAnthracene was then puried by a sucrose gradient ultra-sedimentation. TEM analysis was performed by depositing 20 mL of puried sample onto 100-mesh carbon-coated grids. After waiting for 2 min, the grids were stained with uranyl acetate and viewed with Hitachi-8000 electron microscope. FPLC analysis was performed with AKTA Explorere (Amersham Pharmacia Biotech) equipment, using Superose-6 size-exclusion columns. SDS-PAGE analysis was carried out in Bio-Rad MiniPROTEAN 3 gel electrophoresis cell. CPMV (1 mg) was denatured by heating at 95 C for
2914
F. Xie et al. / Tetrahedron 64 (2008) 2906e2914 11. Speers, A. E.; Adam, G. C.; Cravatt, B. F. J. Am. Chem. Soc. 2003, 125, 4686e4687. 12. Zhou, Z.; Fahrni, C. J. J. Am. Chem. Soc. 2004, 126, 8862e8863. 13. Sivakumar, K.; Xie, F.; Cash, B. M.; Long, S.; Barnhill, H. N.; Wang, Q. Org. Lett. 2004, 6, 4603e4606. 14. Sawa, M.; Hsu, T. L.; Itoh, T.; Sugiyama, M.; Hanson, S. R.; Vogt, P. K.; Wong, C. H. Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 12371e 12376. 15. Hsu, T. L.; Hanson, S. R.; Kishikawa, K.; Wang, S. K.; Sawa, M.; Wong, C. H. Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 2614e2619. 16. Beatty, K. E.; Liu, J. C.; Xie, F.; Dieterich, D. C.; Schuman, E. M.; Wang, Q.; Tirrell, D. A. Angew. Chem., Int. Ed. 2006, 45, 7364e7367. 17. Chang, K. C.; Su, I.; Senthilvelan, A.; Chung, W. Org. Lett. 2007, 9, 3363e3366. 18. Li, X.; Zhang, G.; Ma, H.; Zhang, D.; Li, J.; Zhu, D. J. Am. Chem. Soc. 2004, 126, 11543e11548. 19. Harris, R. F.; Nation, A. J.; Copeland, G. T.; Miller, S. J. J. Am. Chem. Soc. 2000, 122, 11270e11271. 20. Magri, D. C.; Brown, G. J.; McClean, G. D.; de Silva, A. P. J. Am. Chem. Soc. 2006, 128, 4950e4951. 21. Yang, W.; Fan, H.; Gao, X.; Gao, S.; Karnati, V.; Ni, W.; Hooks, W.; Carson, J.; Weston, B.; Wang, B. Chem. Biol. 2004, 11, 439e448. 22. Rostovtsev, V. V.; Green, L. G.; Folkin, V. V.; Sharpless, K. B. Angew. Chem., Int. Ed. 2002, 41, 2596e2599. 23. Tornoe, C. W.; Christensen, C.; Meldal, M. J. Org. Chem. 2002, 67, 3057e3064. 24. Lee, L. A.; Wang, Q. Nanomedicine: Nanotechnology, Biology, and Medicine 2006, 2, 137e149. 25. Wang, Q.; Lin, T.; Tang, L.; Johnson, J. E.; Finn, M. G. Angew. Chem., Int. Ed. 2002, 41, 459e462. 26. Wang, Q.; Lin, T.; Johnson, J. E.; Finn, M. G. Chem. Biol. 2002, 9, 813e819. 27. Wang, Q.; Kaltgrad, E.; Lin, T.; Johnson, J. E.; Finn, M. G. Chem. Biol. 2002, 9, 805e811. 28. Wang, Q.; Raja, K. S.; Janda, K. D.; Lin, T.; Finn, M. G. Bioconjugate Chem. 2003, 14, 38e43. 29. Chatterji, A.; Ochoa, W. F.; Paine, M.; Ratna, B. R.; Johnson, J. E.; Lin, T. Chem. Biol. 2004, 11, 855e863. 30. Sen Gupta, S.; Kuzelka, J.; Singh, P.; Lewis, W. G.; Manchester, M.; Finn, M. G. Bioconjugate Chem. 2005, 16, 1572e1579. 31. Klug, A. Philos. Trans. R. Soc. London, Ser. B: Biol. Sci. 1999, 354, 531e535. 32. Schlick, T. L.; Ding, Z.; Kovacs, E. W.; Francis, M. B. J. Am. Chem. Soc. 2005, 127, 3718e3723. 33. Bruckman, M. A.; Kaur, G.; Lee, L. A; Xie, F.; Sepulveda, J.; Breitenkamp, R.; Zhang, X.; Joralemon, M.; Russell, T. P.; Emrick, T.; Wang, Q. Chembiochem, in press. 34. Schiedel, M. S.; Briehn, C. A.; Bauerle, P. Angew. Chem., Int. Ed. 2001, 40, 4677e4680. 35. Wang, S.; Chang, Y. T. J. Am. Chem. Soc. 2006, 128, 10380e10381. 36. Ahn, Y. H.; Lee, J. S.; Chang, Y. T. J. Am. Chem. Soc. 2007, 129, 4510e4511. 37. Rosania, G. R.; Lee, J. W.; Ding, L.; Yoon, H. S.; Chang, Y. T. J. Am. Chem. Soc. 2003, 125, 1130e1131. 38. Li, Q.; Lee, J. S.; Ha, C.; Park, C. B.; Yang, G.; Gan, W. B.; Chang, Y. T. Angew. Chem., Int. Ed. 2004, 43, 6331e6335. 39. Finney, N. S. Curr. Opin. Chem. Biol. 2006, 10, 238e245. 40. Williams, A. T. R.; Wineld, S. A.; Miller, J. N. Analyst 1983, 108, 1067e1071. 41. Stack, D. E.; Hill, A. L.; Diffendaffer, C. B.; Burns, N. M. Org. Lett. 2002, 4, 4487e4490. 42. Lin, Y.; Lang, S. A.; Seifert, C. M.; Child, R. G.; Morton, G. O.; Fabio, P. F. J. Org. Chem. 1979, 44, 4701e4703. 43. Golden, R.; Stock, L. M. J. Am. Chem. Soc. 1972, 94, 3080e3088.
5 min with TriseHCl buffer containing b-mercaptoethanol, bromophenol blue, and glycerol. The proteins were then resolved on a 15% polyacrylamide gel at 200 V for 1 h. CPMVeAnthracene was visualized with a UVP Epi Chemi II imager under UV irradiation before staining. For analysis by coomassie blue staining, the gel was stained with Bio-Rad Biosafe Coomassie Blue for 1 h and destained with distilled water. 4.7. Labeling of TMV with azide B TMVeAlkyne was prepared using reported procedure.33 Anthracene azide B in a 20% DMSO aqueous solution (100 mM, 40 mL) and TMVeAlkyne (15 mg/mL, 200 mL) were mixed in Tris buffer (10 mM, pH 8.0, 660 mL). Then CuSO4 (100 mM, 10 mL) and sodium ascorbate (200 mM, 10 mL) were added before the mixture was incubated at room temperature for 18 h. The reaction mixture was then puried via an ultra-sedimentation on a 10e50% sucrose gradient column. The collected modied TMV was then pelleted by ultracentrifugation at 160,000g for 2.5 h. The pellet was dissolved in 0.01 M PBS buffer and characterized. Acknowledgements This work was partially supported by the South Carolina EPSCoR/CRP program, the W. M. Keck Foundation, and the NSF-CAREER Program. Supplementary data H and 13C NMR of all the triazole products, the absorption and emission spectra of compounds in Table 1; the optical data of all products from 96-well plate reaction; and the details of making Figure 3. This material is available free of charge via the internet. Supplementary data associated with this article can be found in the online version, at doi:10.1016/j.tet.2008. 01.080. References and notes
1. Prescher, J. A.; Bertozzi, C. R. Nat. Chem. Biol. 2005, 1, 13e21. 2. Link, A. J.; Mock, M. L.; Tirrell, D. A. Curr. Opin. Biotechnol. 2003, 14, 603e609. 3. Wang, L.; Schultz, P. G. Angew. Chem., Int. Ed. 2005, 44, 34e66. 4. Saxon, E.; Bertozzi, C. R. Science 2000, 287, 2007e2010. 5. Gaietta, G.; Deerinck, T. J.; Adams, S. R.; Bouwer, J.; Tour, O.; Laird, D. W.; Sosinsky, G. E.; Tsien, R. Y.; Ellisman, M. H. Science 2002, 296, 503e507. 6. Deiters, A.; Cropp, T. A.; Mukherji, M.; Chin, J. W.; Anderson, J. C.; Schultz, P. G. J. Am. Chem. Soc. 2003, 125, 11782e11783. 7. Lemieux, G. A.; de Graffenried, C. L.; Bertozzi, C. R. J. Am. Chem. Soc. 2003, 125, 4708e4709. 8. Beatty, K. E.; Xie, F.; Wang, Q.; Tirrell, D. A. J. Am. Chem. Soc. 2005, 127, 14150e14151. 9. Wang, Q.; Chan, T. R.; Hilgraf, R.; Fokin, V. V.; Sharpless, K. B.; Finn, M. G. J. Am. Chem. Soc. 2003, 125, 3192e3193. 10. Link, A. J.; Tirrell, D. A. J. Am. Chem. Soc. 2003, 125, 11164e11165.
1